-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexmedetomidine in Bipolar Disorder (Manic Depression)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dexmedetomidine in Bipolar Disorder (Manic Depression) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dexmedetomidine in Bipolar Disorder (Manic Depression) Drug Details: Dexmedetomidine (Igalmi)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexmedetomidine in Opium (Opioid) Addiction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexmedetomidine in Opium (Opioid) Addiction Drug Details: Dexmedetomidine (Igalmi) is an imidazole derivate and active...
-
Product Insights
NewChronic Cough – Drugs In Development, 2024
Empower your strategies with our Chronic Cough – Drugs In Development, 2024 report and make more profitable business decisions. Chronic cough is a respiratory disorder, characterized by a persistent cough lasting at least eight weeks or longer. Coughing is a natural defense mechanism, clearing bronchial secretions and eliminating inhaled foreign particles. Chronic cough can result from various causes, including respiratory infections like bronchitis or pneumonia, gastroesophageal reflux disease (GERD), asthma, and postnasal drip. Understanding and addressing the underlying condition is essential...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexmedetomidine in Dementia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexmedetomidine in Dementia Drug Details: Dexmedetomidine (Igalmi) is an imidazole derivate and active d-isomer of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cebranopadol in Substance (Drug) Abuse
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cebranopadol in Substance (Drug) Abuse Drug Details: Cebranopadol (GRT-6005) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buprenorphine PR in Chronic Low Back Pain (CLBP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buprenorphine PR in Chronic Low Back Pain (CLBP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Buprenorphine PR in Chronic Low Back Pain (CLBP)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Clonidine ER in Sciatica (Sciatic Pain)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Clonidine ER in Sciatica (Sciatic Pain)Drug Details:Clonidine ER is under development for the treatment of sciatic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Oxycodone in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Oxycodone in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Oxycodone in PainDrug Details:Oxycodone (MRX-1OXT) is under development for the treatment of moderate to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Hydrocodone ER in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Hydrocodone ER in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Hydrocodone ER in PainDrug Details:Hydrocodone ER is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Oliceridine in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Oliceridine in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Oliceridine in Pain Drug Details:Oliceridine (Olinvyk) is an opioid agonist. It is formulated as...